Becton Dickinson (BDX)

NYSE Health Care Health Care Equipment S&P 500
$211.88
-1.67 (-0.78%)
Close of Nov 06, 2026 · end-of-day data
Next earnings date
Not scheduled yet
No report date announced in the next three weeks.
Consensus EPS estimate
—
Shown once a date is announced.
Last report (Nov 05)
$4.15 vs $4.06 est.
Surprise +2.2%

Earnings surprise history

reported EPS vs consensus
ReportedQuarterEPS estimateReported EPSSurprise
Nov 05, 2026Sep/2026$4.06$4.15+2.2%

Our record of BDX's reports since we began tracking; it grows each quarter.

Latest results, in brief

All BDX 8-K briefs →
Nov 5, 6:31 AM ET

BDX Reports Q4 Revenue of $5.3 Billion and Issues FY27 Guidance

Neutral earnings 2.02

Becton, Dickinson and Company announced fourth-quarter fiscal 2026 revenue of $5.3 billion, representing a 5.4% increase as reported compared to the prior-year period. Full-year fiscal 2026 revenue reached $19.5 billion, while the company issued fiscal 2027 guidance projecting GAAP and currency-neutral revenue growth in the low single-digits alongside adjusted diluted EPS of $13.10 to $13.30.

  • Q4 revenue grew 5.4% as reported to $5.3 billion, with currency-neutral growth of 5.6%.
  • Q4 GAAP diluted EPS was $2.52 and adjusted diluted EPS was $4.15.
  • Full-year fiscal 2026 cash from continuing operations increased 30.0% to $3.6 billion and free cash flow rose 42.5% to $2.9 billion.
  • Fiscal 2027 guidance projects adjusted diluted EPS between $13.10 and $13.30.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Quarter endedRevenueYoYEPS (diluted)YoYNet incomeNet margin
Jun 2026$4.98B+5.4% $1.37-31.5% $377.00M7.6%
Mar 2026$4.71B+5.2% $-1.11-203.7% -$311.00M-6.6%
Dec 2025$5.25B+1.6% $1.34+28.8% $382.00M7.3%
Sep 2025$8.30B+52.7% $1.72+25.5% $493.00M5.9%
Jun 2025$4.73B-5.3% $2.00+19.0% $574.00M12.1%
Mar 2025$4.48B-11.2% $1.07-42.2% $308.00M6.9%
Dec 2024$5.17B+9.8% $1.04+8.3% $303.00M5.9%
Sep 2024$5.44B+6.9% $1.37+302.9% $400.00M7.4%

From Becton Dickinson's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.

Annual results

Fiscal yearRevenueGrowthEPS (diluted)GrowthNet margin
FY2025$21.84B+8.2% $5.82-0.7%7.7%
FY2024$20.18B+4.2% $5.86+18.6%8.4%
FY2023$19.37B+2.7% $4.94-16.0%7.7%
FY2022$18.87B-1.4% $5.88-14.2%9.4%
FY2021$19.13B+19.0% $6.85+152.8%10.9%

Frequently asked questions

When is Becton Dickinson's next earnings date?

Becton Dickinson has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.

What did Becton Dickinson earn last quarter?

For the quarter ended Jun 2026, Becton Dickinson reported diluted EPS of $1.37 (-31.5% year over year) on revenue of $4.98B (+5.4%).

Where do these numbers come from?

Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.

Not investment advice. Figures can be restated by the company in later filings.